位置:首页 > 蛋白库 > EABN1_BACSU
EABN1_BACSU
ID   EABN1_BACSU             Reviewed;         323 AA.
AC   P94522; Q5MPF4; Q795W7;
DT   20-JAN-2009, integrated into UniProtKB/Swiss-Prot.
DT   07-JUL-2009, sequence version 3.
DT   03-AUG-2022, entry version 126.
DE   RecName: Full=Extracellular endo-alpha-(1->5)-L-arabinanase 1;
DE            Short=ABN;
DE            EC=3.2.1.99;
DE   AltName: Full=Endo-1,5-alpha-L-arabinanase;
DE   Flags: Precursor;
GN   Name=abnA; OrderedLocusNames=BSU28810;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=8969504; DOI=10.1099/13500872-142-11-3067;
RA   Wipat A., Carter N., Brignell C.S., Guy J.B., Piper K., Sanders J.,
RA   Emmerson P.T., Harwood C.R.;
RT   "The dnaB-pheA (256 degrees-240 degrees) region of the Bacillus subtilis
RT   chromosome containing genes responsible for stress responses, the
RT   utilization of plant cell walls and primary metabolism.";
RL   Microbiology 142:3067-3078(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 33-37, FUNCTION,
RP   CATALYTIC ACTIVITY, MUTAGENESIS OF GLU-215, DISRUPTION PHENOTYPE,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND SUBSTRATE
RP   SPECIFICITY.
RC   STRAIN=168;
RX   PubMed=15556708; DOI=10.1016/j.femsle.2004.10.003;
RA   Leal T.F., de Sa-Nogueira I.;
RT   "Purification, characterization and functional analysis of an endo-
RT   arabinanase (AbnA) from Bacillus subtilis.";
RL   FEMS Microbiol. Lett. 241:41-48(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V.,
RA   Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R.,
RA   Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S.,
RA   Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K.,
RA   Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F.,
RA   Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D.,
RA   Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M.,
RA   Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P.,
RA   Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K.,
RA   Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S.,
RA   Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y.,
RA   Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G.,
RA   Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M.,
RA   Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y.,
RA   Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J.,
RA   Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A.,
RA   Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M.,
RA   Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S.,
RA   Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E.,
RA   Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [4]
RP   SEQUENCE REVISION TO 172 AND C-TERMINUS.
RX   PubMed=19383706; DOI=10.1099/mic.0.027839-0;
RA   Barbe V., Cruveiller S., Kunst F., Lenoble P., Meurice G., Sekowska A.,
RA   Vallenet D., Wang T., Moszer I., Medigue C., Danchin A.;
RT   "From a consortium sequence to a unified sequence: the Bacillus subtilis
RT   168 reference genome a decade later.";
RL   Microbiology 155:1758-1775(2009).
RN   [5]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND INDUCTION.
RC   STRAIN=168;
RX   PubMed=14973026; DOI=10.1128/jb.186.5.1287-1296.2004;
RA   Raposo M.P., Inacio J.M., Mota L.J., de Sa-Nogueira I.;
RT   "Transcriptional regulation of genes encoding arabinan-degrading enzymes in
RT   Bacillus subtilis.";
RL   J. Bacteriol. 186:1287-1296(2004).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 31-323 IN COMPLEX WITH CALCIUM
RP   IONS, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF HIS-43;
RP   ASP-44; TRP-104; PHE-124; ASP-163; PHE-181; TRP-182 AND GLU-215, COFACTOR,
RP   AND SUBSTRATE SPECIFICITY.
RX   PubMed=15708971; DOI=10.1073/pnas.0500051102;
RA   Proctor M.R., Taylor E.J., Nurizzo D., Turkenburg J.P., Lloyd R.M.,
RA   Vardakou M., Davies G.J., Gilbert H.J.;
RT   "Tailored catalysts for plant cell-wall degradation: redesigning the
RT   exo/endo preference of Cellvibrio japonicus arabinanase 43A.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:2697-2702(2005).
CC   -!- FUNCTION: Involved in the degradation of arabinan and is a key enzyme
CC       in the complete degradation of the plant cell wall. Catalyzes the
CC       internal cleavage of alpha-(1->5)-L-arabinofuranosyl residues of linear
CC       1,5-alpha-L-arabinan and of branched sugar beet arabinan. It displays
CC       no activity against heavily substituted arabinans or a range of other
CC       polysaccharides (larch wood arabinogalactan, wheat arabinoxylan and p-
CC       nitrophenyl-alpha-L-arabinofuranoside). The enzyme activity is
CC       progressively reduced as alpha-(1->5)-chains become shorter or more
CC       highly substituted. {ECO:0000269|PubMed:14973026,
CC       ECO:0000269|PubMed:15556708, ECO:0000269|PubMed:15708971}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endohydrolysis of (1->5)-alpha-arabinofuranosidic linkages in
CC         (1->5)-arabinans.; EC=3.2.1.99;
CC         Evidence={ECO:0000269|PubMed:15556708};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000305};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000305};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.5 mM for arabinotetraose (at 27 degrees Celsius and pH 7)
CC         {ECO:0000269|PubMed:15556708, ECO:0000269|PubMed:15708971};
CC         KM=5.92 mM for linear 1,5-alpha-L-arabinan (at 37 degrees Celsius and
CC         pH 6.6) {ECO:0000269|PubMed:15556708, ECO:0000269|PubMed:15708971};
CC         Vmax=1.31 mmol/min/mg enzyme (at 37 degrees Celsius and pH 6.6)
CC         {ECO:0000269|PubMed:15556708, ECO:0000269|PubMed:15708971};
CC       pH dependence:
CC         Optimum pH is 6.0. At pH 4.0 the arabinosidase retains about 8% of
CC         activity. {ECO:0000269|PubMed:15556708, ECO:0000269|PubMed:15708971};
CC       Temperature dependence:
CC         Optimum temperature is 60 degrees Celsius. At 80 degrees Celsius
CC         retains about 2% of activity. {ECO:0000269|PubMed:15556708,
CC         ECO:0000269|PubMed:15708971};
CC   -!- PATHWAY: Glycan metabolism; L-arabinan degradation.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15556708}.
CC   -!- INDUCTION: Induced by arabinose and arabina,n and repressed by glucose.
CC       {ECO:0000269|PubMed:14973026}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene retains about 40% of the
CC       capacity to hydrolyze linear arabinan compared to the wild-type.
CC       {ECO:0000269|PubMed:14973026, ECO:0000269|PubMed:15556708}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 43 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA99586.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z75208; CAA99586.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AY669857; AAV87172.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB14841.2; -; Genomic_DNA.
DR   PIR; E69580; E69580.
DR   RefSeq; NP_390759.2; NC_000964.3.
DR   PDB; 1UV4; X-ray; 1.50 A; A=31-323.
DR   PDBsum; 1UV4; -.
DR   AlphaFoldDB; P94522; -.
DR   SMR; P94522; -.
DR   STRING; 224308.BSU28810; -.
DR   CAZy; GH43; Glycoside Hydrolase Family 43.
DR   PaxDb; P94522; -.
DR   PRIDE; P94522; -.
DR   EnsemblBacteria; CAB14841; CAB14841; BSU_28810.
DR   GeneID; 937430; -.
DR   KEGG; bsu:BSU28810; -.
DR   PATRIC; fig|224308.179.peg.3129; -.
DR   eggNOG; COG3507; Bacteria.
DR   InParanoid; P94522; -.
DR   OMA; RYDNGWP; -.
DR   PhylomeDB; P94522; -.
DR   BioCyc; BSUB:BSU28810-MON; -.
DR   BioCyc; MetaCyc:BSU28810-MON; -.
DR   SABIO-RK; P94522; -.
DR   UniPathway; UPA00667; -.
DR   EvolutionaryTrace; P94522; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0046558; F:arabinan endo-1,5-alpha-L-arabinosidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031222; P:arabinan catabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 2.115.10.20; -; 1.
DR   InterPro; IPR006710; Glyco_hydro_43.
DR   InterPro; IPR016840; Glyco_hydro_43_endo_a_Ara-ase.
DR   InterPro; IPR023296; Glyco_hydro_beta-prop_sf.
DR   Pfam; PF04616; Glyco_hydro_43; 1.
DR   PIRSF; PIRSF026534; Endo_alpha-L-arabinosidase; 1.
DR   SUPFAM; SSF75005; SSF75005; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Carbohydrate metabolism; Direct protein sequencing;
KW   Glycosidase; Hydrolase; Metal-binding; Reference proteome; Secreted;
KW   Signal.
FT   SIGNAL          1..32
FT                   /evidence="ECO:0000269|PubMed:15556708"
FT   CHAIN           33..323
FT                   /note="Extracellular endo-alpha-(1->5)-L-arabinanase 1"
FT                   /id="PRO_0000360437"
FT   ACT_SITE        44
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:15708971"
FT   ACT_SITE        215
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:15708971"
FT   BINDING         44
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         107
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255"
FT   BINDING         125
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         160..163
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         165
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255"
FT   BINDING         180..182
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         287
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255"
FT   SITE            163
FT                   /note="Important for catalytic activity, responsible for
FT                   pKa modulation of the active site Glu and correct
FT                   orientation of both the proton donor and substrate"
FT                   /evidence="ECO:0000305|PubMed:15708971"
FT   MUTAGEN         43
FT                   /note="H->A: Decrease in binding affinity."
FT                   /evidence="ECO:0000269|PubMed:15708971"
FT   MUTAGEN         44
FT                   /note="D->A: Loss of arabinanase activity."
FT                   /evidence="ECO:0000269|PubMed:15708971"
FT   MUTAGEN         104
FT                   /note="W->A: Significantly less active (10000-fold) than
FT                   the wild-type arabinanase against both linear arabinan and
FT                   arabinooligosaccharides."
FT                   /evidence="ECO:0000269|PubMed:15708971"
FT   MUTAGEN         124
FT                   /note="F->A: Increase in binding affinity."
FT                   /evidence="ECO:0000269|PubMed:15708971"
FT   MUTAGEN         163
FT                   /note="D->A: Loss of arabinanase activity."
FT                   /evidence="ECO:0000269|PubMed:15708971"
FT   MUTAGEN         181
FT                   /note="F->A: Significantly less active than the wild-type
FT                   arabinanase against both linear arabinan (50-fold) and the
FT                   arabinooligosaccharides (1000-fold)."
FT                   /evidence="ECO:0000269|PubMed:15708971"
FT   MUTAGEN         182
FT                   /note="W->A: Same binding affinity as wild-type."
FT                   /evidence="ECO:0000269|PubMed:15708971"
FT   MUTAGEN         215
FT                   /note="E->A: Loss of arabinanase activity."
FT                   /evidence="ECO:0000269|PubMed:15556708,
FT                   ECO:0000269|PubMed:15708971"
FT   CONFLICT        172
FT                   /note="G -> D (in Ref. 1; CAA99586)"
FT                   /evidence="ECO:0000305"
FT   STRAND          34..41
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          46..50
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          53..59
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          64..77
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          79..84
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   HELIX           90..94
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          104..111
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          114..121
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          129..137
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   TURN            139..142
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          145..153
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          157..159
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          165..168
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          174..178
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          185..190
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   TURN            192..194
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          196..205
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   TURN            208..212
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          214..222
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          225..233
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          235..239
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          242..252
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   HELIX           265..267
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          271..274
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          278..289
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   TURN            290..292
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          293..300
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   TURN            301..305
FT                   /evidence="ECO:0007829|PDB:1UV4"
FT   STRAND          307..313
FT                   /evidence="ECO:0007829|PDB:1UV4"
SQ   SEQUENCE   323 AA;  35446 MW;  0105FB280E83BC69 CRC64;
     MKKKKTWKRF LHFSSAALAA GLIFTSAAPA EAAFWGASNE LLHDPTMIKE GSSWYALGTG
     LTEERGLRVL KSSDAKNWTV QKSIFTTPLS WWSNYVPNYG QNQWAPDIQY YNGKYWLYYS
     VSSFGSNTSA IGLASSTSIS SGGWKDEGLV IRSTSSNNYN AIDPELTFDK DGNPWLAFGS
     FWSGIKLTKL DKSTMKPTGS LYSIAARPNN GGALEAPTLT YQNGYYYLMV SFDKCCDGVN
     STYKIAYGRS KSITGPYLDK SGKSMLEGGG TILDSGNDQW KGPGGQDIVN GNILVRHAYD
     ANDNGIPKLL INDLNWSSGW PSY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024